CORT125134

· Corcept Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CORT125134, covering 2019-09-25 to 2019-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate CORT125134 in Participants With Cushing's Syndrome [Phase 2]